End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
184.5 TWD | +1.37% | -0.27% | +170.13% |
May. 14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
May. 14 | Lumosa Therapeutics Co., Ltd. Announces the Change in Juristic-Person Director Representative | CI |
Sales 2024 * | 59M 1.83M | Sales 2025 * | 816M 25.32M | Capitalization | 30.44B 944M |
---|---|---|---|---|---|
Net income 2024 * | -444M -13.78M | Net income 2025 * | 786M 24.39M | EV / Sales 2024 * | 512 x |
Net cash position 2024 * | 259M 8.04M | Net cash position 2025 * | 954M 29.6M | EV / Sales 2025 * | 36.1 x |
P/E ratio 2024 * |
-68.6
x | P/E ratio 2025 * |
38.8
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.33% |
1 day | +1.37% | ||
1 week | -0.27% | ||
Current month | +7.27% | ||
1 month | +3.07% | ||
3 months | +38.20% | ||
6 months | +194.26% | ||
Current year | +170.13% |
Managers | Title | Age | Since |
---|---|---|---|
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
Chia Chi Yang
DFI | Director of Finance/CFO | - | 22-01-31 |
June Kuo
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 14-07-24 |
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
I Hsiung Chang
BRD | Director/Board Member | - | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 184.5 | +1.37% | 284,934 |
24-05-23 | 182 | 0.00% | 291,082 |
24-05-22 | 182 | -1.09% | 226,738 |
24-05-21 | 184 | +1.38% | 180,548 |
24-05-20 | 181.5 | -1.89% | 347,521 |
End-of-day quote Taipei Exchange, May 23, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.13% | 931M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- 6535 Stock